Navigation Links
5i Sciences Announces Appointment of a Senior Healthcare Consultant and Successful Financing
Date:7/22/2014

San Diego, CA (PRWEB) July 22, 2014

5i Sciences, a medical technology company focused on airway management products, announced the appointment of Molly Coye, M.D., M.P.H. to a role as Senior Consultant. Dr. Coye is an internationally renowned authority on the market introduction of innovative technologies that impact healthcare delivery. It is expected that she will advise on strategies for building a successful commercial healthcare enterprise based on the Company’s proprietary cNEP® technology. Dr. Coye is currently the Chief Innovation Officer of UCLA Health, and serves as a Director of Aetna, Inc. and Prosetta Biosciences, Inc. She founded and was CEO of the Health Technology Center, a preeminent forecaster of the impact of emerging technologies. She is a member of the prestigious Institute of Medicine and co-authored two landmark Institute reports on healthcare quality.

“The appointment of a Senior Consultant of Dr. Coye’s stature is an important achievement and opportunity for our Company,” said Dr. Richard Rose, President and CEO. “Given her extensive experience in evaluating emerging healthcare technologies, it is gratifying that she has chosen to work with 5i, which is further validation of the potential of our cNEP® technology for improving healthcare. We are delighted to have the opportunity to work closely with Dr. Coye as we identify strategies for maximizing the impact of our cNEP® products as they are introduced into the markets for hospital based airway management and sleep medicine.”

Dr. Coye commented, “I am very pleased to have the opportunity to advise 5i Sciences in the further development of their technology and products, because they target some of the most clinically important and widespread conditions affecting patients. The potential of the cNEP technology for improving outcomes and patient experience in both hospital and home settings is very promising.”

The Company also announced completion of a Series B financing that raised $2.5 million and resulted in the conversion of $2.9MM in convertible Notes, $2 MM of which, was previously announced. Dr. Rose indicated that these funds will be used to further the development of products for airway management in anesthesia care and sleep medicine.

Avram Miller, Vice-Chairman, remarked “Over the last twelve months, 5i Sciences has made significant progress in strengthening its board and management team, and advancing the development of its core technology. The more than five million dollars that the company has raised provides a solid financial foundation which will allow the company to bring its first products to market.”

About 5i Sciences:
5i Sciences is developing its proprietary continuous negative external pressure (cNEP®) technology for important medical and consumer applications. The Company is dedicated to offering simple to use, safe and well-tolerated products that keep the upper airway open. For more information, visit http://www.5iSciences.com.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12035379.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Western University of Health Sciences Elevated to “Great College to Work For” Honor Roll
2. NSU’s Graduate School of Computer and Information Sciences to Hold Special Presentations on Top 5 Technology Trends to Impact Business & IT Leaders
3. California Healthcare Institute Adds Executives from Gilead Sciences, Cedars-Sinai and Versant Ventures to Its Board
4. Miraca Life Sciences’ PathConnect System Achieves ONC HIT 2014 Edition Modular EHR Certification from ICSA Labs
5. UMMS scientist named 2014 Pew Latin American Fellow in the biomedical sciences
6. St. Jude Childrens Research Hospital scientist elected to National Academy of Sciences
7. BIDMCs Martin Pollak, M.D., elected to National Academy of Sciences
8. Wyss Institute Core Faculty member elected to the National Academy of Sciences
9. Norwegian neuroscientists elected to National Academy of Sciences
10. Miraca Life Sciences Announces Significant Tradeshow Plans for the Annual Meeting of the American Academy of Dermatology
11. Helping Children with Autism Using Brain Training Apps from C8 Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... The Wharton School of ... Julie Taffet Moelis, W’81, have made a $10 million gift to establish the ... that will provide a pathway to a Wharton MBA for highly-qualified Penn undergraduates whose ...
(Date:3/29/2017)... ... March 29, 2017 , ... VisualSP has helped over 1.5 ... the only option for on-premises installation of its Help System for SharePoint was at ... the system into the entire tenant. , The company recently released a modified ...
(Date:3/28/2017)... ... March 28, 2017 , ... Tuesday, March 28, 2017, ... public to take the Diabetes Risk Test to find out if they are at ... World Airports will light up the evening sky by programming the LAX pylons the ...
(Date:3/28/2017)... NEW YORK, NEW YORK (PRWEB) , ... March ... ... their breakthrough development, NTX Technology™, is the first technology to directly address the ... World Health Organization. NTX Technology™ is a patented compound of FDA and TTB ...
(Date:3/28/2017)... ... 2017 , ... Resoundant, Inc., the developer of Magnetic ... annual customer education symposium, a world-class learning conference that offers educational content designed ... 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , Innovations for ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017 Research and Markets has announced the ... Market Outlook: 2016-2022" report to their offering. ... The global patient safety and ... delivery, end-user, and geography. Patient safety has become ... The field has developed significantly in the last decade and is ...
(Date:3/28/2017)... , March 28, 2017 "Chemotherapy Induced Neutropenia (CIN) – ... the disease and global market trends of the Chemotherapy Induced Neutropenia ... , Europe ( France , ... Spain , UK) and Japan , ... and rest of the world (RoW). The Report covers ...
(Date:3/28/2017)...  Medeon Biodesign, Inc., a Taiwan ... announce that the Company led and successfully closed ... a San Jose, CA ... extremity applications.  The orthopedic extremity ... to procedure volume growth, lifestyle influences and favorable ...
Breaking Medicine Technology: